660 related articles for article (PubMed ID: 24926520)
1. Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.
Prescrire Int; 2014 May; 23(149):130-5. PubMed ID: 24926520
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
4. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
7. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
8. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
9. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
10. Abnormal uterine bleeding: managing endometrial dysfunction and leiomyomas.
Brennan A; Hickey M
Med J Aust; 2018 Feb; 208(2):90-95. PubMed ID: 29385977
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Kriplani A; Awasthi D; Kulshrestha V; Agarwal N
Int J Gynaecol Obstet; 2012 Jan; 116(1):35-8. PubMed ID: 21959070
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
13. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
14. Ulipristal acetate versus placebo for fibroid treatment before surgery.
Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
[TBL] [Abstract][Full Text] [Related]
15. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
16. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
17. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from the preclinical drug discovery of asoprisnil and ulipristal for non-surgical treatment of uterine leiomyomas.
Maruo T; Ohara N; Yoshida S; Nakabayashi K; Sasaki H; Xu Q; Matsuo H; Sitruk-Ware R; Yamada H
Expert Opin Drug Discov; 2011 Sep; 6(9):897-911. PubMed ID: 22646213
[TBL] [Abstract][Full Text] [Related]
19. [Management of menometrorrhagia in women with and without pregnancy intention: hierarchy of therapies].
Roman H; Loisel C; Puscasiu L; Sentilhes L; Marpeau L
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S405-17. PubMed ID: 19268219
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]